Skip to main content
Clinical Trials/IRCT20200825048515N55
IRCT20200825048515N55Not yet recruitingPhase 3

Effect of different doses of ketamine on prevention of fentanyl induced coughing during general anesthesia induction

Esfahan University of Medical Sciences0 sites56 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Enrollment
56

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 65 years (—)
Sex
All

Inclusion Criteria

  • Age category 65-18 years
  • Candidate for surgery under general anesthesia using fentanyl
  • American Society of Anesthesiologists (ASA) I or II
  • Satisfaction to participate in the study

Exclusion Criteria

  • Underlying diseases (including heart failure, respiratory, liver, kidney, myocardial ischemic disease, myocardial infarction, hypertension above 140/90 mm Hg, tachycardia (heart rate above 100 beats per minute), depression, asthma, chronic cough)
  • History of allergy to the studied drugs
  • Smoking, addiction
  • Having an upper respiratory infection within the last month
  • Use of drugs such as angiotensin converting enzyme inhibitors (ACEIs), antidepressants (over the past two weeks), and steroids (over the past two weeks) that interfere with the study

Investigators

Similar Trials